A pioneer in cancer vaccine development, AVAX Technologies, Inc. is an internationally integrated biotechnology company focused on developing and commercializing its AC Vaccine® technology for the treatment of cancer.
Although subject to the same FDA regulations as other biological products, vaccines are inherently more difficult to develop, characterize, and manufacture than most pharmaceutical products. Vaccine development and commercialization is a long complex process. Avax is a leader in terms of stage of development and commercial readiness in the immuno-oncology arena. Today, the GMP approved facility is in Philadelphia and represents one of the very few autologous vaccine approved production facilities in the world.
www.avax-tech.com
Company Details
- Founded
- -
- Address
- Philadelphia, Us
- Phone
- (215)241-9760
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- avax-tech.com
- Keywords
- Faridabad.
- HQ
- Philadelphia
Avax Technologies, Inc. Questions
Avax Technologies, Inc.'s helpline number is (215)241-9760
Avax Technologies, Inc.'s website is avax-tech.com
Avax Technologies, Inc.'s LinkedIn profile is https://www.linkedin.com/company/avax-technologies
Avax Technologies, Inc.'s industry is
Biotechnology Research
Avax Technologies, Inc.'s top competitors are
Medbar,
Avax Group,
Avax Digital,
Avaxo De México,
Rasdelta Wellness Private Limited,
Avax Sa 410,
Target Media Network,
G-Sat International Pvt Ltd,
Avax Digital,
Avax.
Avax Technologies, Inc.'s categories are Biotechnology Research
Avax Technologies, Inc.'s founding year is 1998
